trending Market Intelligence /marketintelligence/en/news-insights/trending/hi6c5obiut3a_xd8lk_hpq2 content esgSubNav
In This List

LivaNova to acquire Pittsburgh-based medical device company for $250M

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


LivaNova to acquire Pittsburgh-based medical device company for $250M

LivaNova PLC agreed to acquire Pittsburgh-based privately held medical device company TandemLife for $250 million.

TandemLife is focused on developing advanced cardiopulmonary temporary support solutions. LivaNova said TandemLife's systems are complementary to its offerings in cardiac surgery.

London-based LivaNova will pay a total of $200 million upfront for TandemLife, with up to $50 million in contingent considerations based on regulatory milestones.

The deal is expected to close in the first half of 2018, subject to approvals and other customary closing conditions, and is expected to be modestly accretive in 2018.